ID: ALA4572583

Max Phase: Preclinical

Molecular Formula: C15H13N

Molecular Weight: 207.28

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C/C(C#N)=C\c1ccc(C)c2ccccc12

Standard InChI:  InChI=1S/C15H13N/c1-11(10-16)9-13-8-7-12(2)14-5-3-4-6-15(13)14/h3-9H,1-2H3/b11-9+

Standard InChI Key:  WMDIKNFCQSFTCM-PKNBQFBNSA-N

Associated Targets(Human)

GABA-A receptor; alpha-1/beta-3/gamma-2 1565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 207.28Molecular Weight (Monoisotopic): 207.1048AlogP: 4.08#Rotatable Bonds: 1
Polar Surface Area: 23.79Molecular Species: HBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.26CX LogD: 4.26
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.65Np Likeness Score: -0.19

References

1. Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S..  (2018)  Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators.,  62  (1): [PMID:30289721] [10.1021/acs.jmedchem.8b00859]

Source